Dana-Farber Research Opens the Door to Finding More Effective Treatments for Ewing Sarcoma

Dana-Farber Cancer Institute | |

<p>In 2014,&#160;Dana-Farber pediatric oncologist&#160;Brian Crompton, MD, discovered that&#160;a gene called&#160;STAG2&#160;is mutated in about 15 percent of&#160;patients with&#160;Ewing sarcoma, a form of bone cancer that&#160;largely occurs&#160;in children and adolescents.&#160;Now,&#160;that molecular&#160;insight&#160;could hold the keys to advancing treatment&#160;for the disease.&#160;&#160; New research led by&#160;senior authors&#160;Crompton and&#160;pediatric oncologist&#160;Katherine Janeway, MD,&#160;Dana-Farber Pediatric Oncology Section Chief and Chair of the Children’s ... <a class="read-more" href="https://blog.dana-farber.org/insight/2025/11/dana-farber-research-opens-the-door-to-finding-more-effective-treatments-for-ewing-sarcoma/" title="Dana-Farber…

Topics: skin-cancer, blood-cancer, cervical-cancer, sarcoma, pediatric-cancer, research